tiprankstipranks
Trending News
More News >
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
US Market

Bioxcel Therapeutics (BTAI) Ownership - Who Owns Bioxcel Therapeutics?

Compare
1,450 Followers

Bioxcel Therapeutics (BTAI) Ownership Overview

12.36%0.97%2.74%0.38%83.55%
12.36% Insiders
2.74% Other Institutional Investors
0.38% ETFs
83.55% Public Companies and Individual Investors
The ownership structure of Bioxcel Therapeutics (BTAI) stock is a mix of institutional, retail, and individual investors. Approximately 4.09% of the company’s stock is owned by Institutional Investors, 12.36% is owned by Insiders, and 83.55% is owned by Public Companies and Individual Investors.
The ownership structure of Bioxcel Therapeutics (BTAI) stock is a mix of institutional, retail, and individual investors. Approximately 3.71% of the company’s stock is owned by Institutional Investors, 12.36% is owned by Insiders, and 0.38% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 06, 2024
xxxxxxxxxxxxx
$404505

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
484,572Insider8.00%707,475
209,795Insider3.46%306,301
29,713Institution0.49%43,381
19,957Insider0.33%29,137
19,011Insider0.31%27,756
18,331Institution0.30%26,763
16,935Institution0.28%24,725
14,808Institution0.24%21,620
10,158Insider0.17%14,831
6,609Institution0.11%9,649

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
29,713Institution0.49%43,381
16,935Institution0.28%24,725
14,808Institution0.24%21,620
6,609Institution0.11%9,649
2,135Institution0.04%3,117

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
18,331Institution0.30%33,912
4,567Institution0.08%6,668

FAQ

Who Owns Bioxcel Therapeutics Inc (BTAI)?
According to the latest TipRanks data, approximately 2.74% of the company's stock is held by institutional investors, 12.36% is held by insiders, and 83.55% is held by retail investors.
    What percentage of Bioxcel Therapeutics Inc (BTAI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.74% of Bioxcel Therapeutics Inc (BTAI) stock is held by institutional investors.
      What percentage of Bioxcel Therapeutics Inc (BTAI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 83.55% of Bioxcel Therapeutics Inc (BTAI) stock is held by retail investors.
        Who owns the most shares of Bioxcel Therapeutics Inc (BTAI)?
        Vimal Mehta owns the most shares of Bioxcel Therapeutics Inc (BTAI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis